Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Epidemiological study (cross-sectional study) in order to determine the patients who present an adequate control of the Blood Pressure (BP), in a population of Colombian patients diagnosed with Arterial Hypertension (AH) and who are under pharmacological treatment.
OBJECTIVE: To determine the proportion of patients who present an adequate control of the Blood Pressure (BP), in a population of Colombian patients diagnosed with Arterial Hypertension (AH) and who are under pharmacological treatment.
MATERIALS AND METHODS: Epidemiological study (cross-sectional study), multicentre type, in patients older than 18 years with prior diagnosis of AH in Colombia. The blood pressure control will be evaluated as the main variable (only one single blood pressure check in the doctor's office). Other secondary variables to evaluate are: demographical analysis, type (s) of antihypertensive treatment (s) used in patients, level of BP control, adverse events associated with antihypertensive treatment, comorbidities and risk factors, adherence, perception about the possible benefits of the use of combined therapy in "mono-tablet" versus "multi-tablet". The analysis will be carried out from two perspectives: A first descriptive approach and a second analytical approach, with a level of significance of 5%.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Patients with adequate control of the Blood Pressure (BP) | Proportion of patients who present an adequate control of the Blood Pressure (BP) | It will be evaluated in each patient (only once, at the time of the interview) throughout the study which is estimated to last 3 years. |
| Measure | Description | Time Frame |
|---|---|---|
| Demographic analysis | Characterization of patients | It will be evaluated in each patient (only once, at the time of the interview) throughout the study which is estimated to last 3 years. |
| Treatment analysis |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Colombian patients
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Javier Castillo, Dr | Contact | +571-6461700 | jcastill@scandinavia.com.co | |
| Ferrari Claudio, Dr | Contact | +571-6461700 | cferrari@scandinavia.com.co |
| Name | Affiliation | Role |
|---|---|---|
| Javier Castillo, Dr | Scandinavia Pharma | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Scandinavia Pharma | Recruiting | Bogotá | 110111 | Colombia |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D006973 | Hypertension |
| ID | Term |
|---|---|
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Characterization of treatment (s) used
| It will be evaluated in each patient (only once, at the time of the interview) throughout the study which is estimated to last 3 years. |
| Personal history of diseases | Evaluation of personal history of diseases | It will be evaluated in each patient (only once, at the time of the interview) throughout the study which is estimated to last 3 years. |
| Adverse Events related with the treatment | Adverse events associated with the treatment (s) | It will be evaluated in each patient (only once, at the time of the interview) throughout the study which is estimated to last 3 years. |